Global Hospital-Acquired Infection Control Market
HealthcareServices

Global Hospital-Acquired Infection Control Industry Insights: Key Trends and Growth Estimates

Uncover key drivers, emerging technologies, and competitive movements shaping the hospital-acquired infection control market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Hospital-Acquired Infection Control Market expected to reach by 2030?

The hospital-acquired infection control market size has experienced substantial growth in recent years. It is anticipated to increase from $35.75 billion in 2025 to $37.7 billion by 2026, progressing at a compound annual growth rate (CAGR) of 5.4%. The expansion observed in the historic period can be attributed to a higher incidence of hospital-acquired infections, the augmented use of invasive medical procedures, increased awareness concerning patient safety standards, the enlargement of intensive care units, and more rigorous hospital hygiene regulations.

The market for controlling hospital-acquired infections is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $46.32 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the forecast period include more stringent regulatory enforcement concerning infection control, a greater uptake of automated sterilization methods, an escalating need for swift microbial testing, the broadening of surveillance and reporting frameworks, and increased funding for hospital infection prevention facilities. Key trends expected over the forecast period involve a heightened focus on avoiding cross-contamination within hospitals, an increase in the implementation of sophisticated sterilization and disinfection procedures, a stronger emphasis on ongoing infection monitoring, the wider availability of automated and high-level disinfection remedies, and a greater call for all-encompassing infection prevention initiatives.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp

What Drivers Are Driving Adoption Within The Hospital-Acquired Infection Control Market?

The growth of the hospital-acquired infection control market is anticipated to be driven by increasing healthcare expenditures. These expenditures denote the overall financial outlay on healthcare-related services, products, and activities within a specified duration, generally at an individual, community, national, or global scale. As healthcare spending rises, hospitals and healthcare facilities are expected to allocate additional funds for the implementation of advanced infection prevention technologies. This includes innovative solutions like sophisticated disinfection systems, intelligent monitoring devices, and other technologies designed to enhance comprehensive infection control measures. For instance, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure grew by 5.6% in nominal terms between 2022 and 2023, which is a considerable increase compared to the 0.9% growth observed in 2022. Consequently, the rising healthcare expenditure will further propel the expansion of the hospital-acquired infection control market.

What Segments Are Included Within The Hospital-Acquired Infection Control Market?

The hospital-acquired infection control market covered in this report is segmented –

1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products

2) By Technology: Phenotypic Methods, Genotypic Methods

3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases

4) By Application: Disease Testing, Drug-Resistance Testing

5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users

Subsegments:

1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers

2) By Disinfectors: Washer Disinfectors, Automated Disinfectors

3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors

4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems

5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)

6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds

7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software

8) By Other Products: Cleaning Equipment, Air Purification Systems

Which Trends Are Influencing The Performance And Direction Of The Hospital-Acquired Infection Control Market?

Companies operating in the hospital-acquired infection control market are focused on developing new technological solutions, such as AI systems, to facilitate early identification of sepsis, thereby enhancing patient outcomes through rapid diagnosis and treatment. An AI system designed to identify sepsis refers to advanced technological solutions that utilize artificial intelligence and machine learning algorithms for detecting the early signs of sepsis in patients. For instance, in April 2024, Prenosis Inc., a US-based medical clinic, received FDA marketing authorization for the Sepsis ImmunoScore, marking it as the first AI-driven system created to predict sepsis, a life-threatening condition that can result in severe complications. This innovative tool enhances early detection by analyzing data in real-time, enabling healthcare professionals to intervene more swiftly and effectively. The integration of AI is intended to support, rather than replace, medical staff in their decision-making, ultimately leading to improved patient outcomes and a reduction in healthcare costs.

Who Are The Major Companies Operating In The Hospital-Acquired Infection Control Market?

Major companies operating in the hospital-acquired infection control market are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Hospital-Acquired Infection Control Market?

North America was the largest region in the hospital-acquired infection control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hospital-Acquired Infection Control Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7694&type=smp

Browse Through More Reports Similar to the Global Hospital-Acquired Infection Control Market 2026, By The Business Research Company

Infection Control Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Surgical Site Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-site-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model